APA (7th ed.) Citation

Haghmorad, D., Yousefi, B., Eslami, M., Rashidy-Pour, A., Tarahomi, M., Tavaf, M. J., . . . Oksenych, V. (2022). Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. MDPI AG.

Chicago Style (17th ed.) Citation

Haghmorad, Dariush, et al. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis Through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. MDPI AG, 2022.

MLA (9th ed.) Citation

Haghmorad, Dariush, et al. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis Through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. MDPI AG, 2022.